Company Filing History:
Years Active: 2001
Title: Jerome Pugin: Innovator in Antibody Therapeutics
Introduction
Jerome Pugin is a notable inventor based in Puplinge, Switzerland. He has made significant contributions to the field of medicine, particularly in the treatment of infections caused by Gram-positive bacteria and mycobacteria. His innovative approach focuses on utilizing antibodies to combat serious health conditions.
Latest Patents
Pugin holds a patent for the "Use of antibodies to block the effects of gram-positive bacteria and mycobacteria." This invention addresses a method for treating bacteremia, sepsis, and other forms of toxemia caused by these bacteria. The patent outlines the administration of a therapeutically effective amount of anti-CD14 antibody molecules. Additionally, it includes a therapeutic composition comprising these antibody molecules in a pharmaceutically acceptable excipient.
Career Highlights
Jerome Pugin is affiliated with The Scripps Research Institute, where he has been involved in groundbreaking research. His work has contributed to advancements in therapeutic strategies for bacterial infections, showcasing his commitment to improving patient outcomes.
Collaborations
Pugin has collaborated with esteemed colleagues such as Richard J. Ulevitch and Peter S. Tobias. These partnerships have further enhanced the impact of his research and innovations in the medical field.
Conclusion
Jerome Pugin's contributions to antibody therapeutics exemplify the importance of innovation in medicine. His patent and ongoing research continue to pave the way for new treatment options for serious bacterial infections.